论文部分内容阅读
胎儿生长受限(fetal growth restriction,FGR)是围生期常见的并发症之一,发生率约为6.39%。FGR胎儿在围生期易出现缺氧、窒息、酸中毒等,对产程的耐受性差,围生儿死亡率较正常增高6～9倍。FGR患者生长及智力发育缓慢、滞后;成年后是发生内分泌代谢障碍、心血管疾病、阻塞性肺疾病、肾脏疾病和内分泌代谢障碍等疾病的高危人群。因此对FGR应及早发现,及早治疗,对已发生FGR者在宫内进行及时、有效的治疗就十分重要,对围生儿的预后也产生积极的影响。
Fetal growth restriction (FGR) is a common perinatal complications, the incidence was about 6.39%. FGR fetus in the perinatal prone to hypoxia, asphyxia, acidosis, poor tolerance of the labor process, perinatal mortality than normal 6 to 9 times. FGR patients with slow growth and mental retardation, lag; adult endocrine and metabolic disorders occur, cardiovascular disease, obstructive pulmonary disease, kidney disease and endocrine disorders such as high-risk groups. Therefore, the FGR should be detected early, early treatment, FGR in patients with intrauterine have been timely and effective treatment is very important, the prognosis of perinatal children also have a positive impact.